Neonatal intravenous injection of a gammaretroviral vector has a low incidence of tumor induction in mice.
about
A self-inactivating gamma-retroviral vector reduces manifestations of mucopolysaccharidosis I in miceGene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model.Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins.Perinatal gene transfer to the liver.
P2860
Neonatal intravenous injection of a gammaretroviral vector has a low incidence of tumor induction in mice.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Neonatal intravenous injection ...... ce of tumor induction in mice.
@ast
Neonatal intravenous injection ...... ce of tumor induction in mice.
@en
type
label
Neonatal intravenous injection ...... ce of tumor induction in mice.
@ast
Neonatal intravenous injection ...... ce of tumor induction in mice.
@en
prefLabel
Neonatal intravenous injection ...... ce of tumor induction in mice.
@ast
Neonatal intravenous injection ...... ce of tumor induction in mice.
@en
P2093
P2860
P356
P1433
P1476
Neonatal intravenous injection ...... ce of tumor induction in mice.
@en
P2093
Katherine P Ponder
Lingfei Xu
Mindy Tittiger
P2860
P304
P356
10.1089/HUM.2008.070
P577
2008-11-01T00:00:00Z